ConductScience.org, home

Paper29367757

The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.

Hu T and 7 others. Oncogene, 2018. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase. Papers, record 29367757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29367757

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
PubMed
Journal
Oncogene
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2019-03-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu TTianxiang
2Chong YYating
3Qin HHaiyan
4Kitamura EEiko
5Chang CSChang-Sheng
6Silva JJeane
7Ren MMingqiang
8Cowell JKJohn K

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LymphomaMajor topic
MicroRNAsMajor topic
Oncogene Proteins, FusionMajor topic
Proto-Oncogene Proteins c-bcrMajor topic
Receptor, Fibroblast Growth Factor, Type 1Major topic
Animals
Cell Line, Tumor
Cell Proliferation
Female
Gene Expression Regulation, Neoplastic
HEK293 Cells
Humans
Mice
Mice, Inbred BALB C
Multigene Family
Syndrome

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA076167NCI NIH HHSUnited StatesR01CA076167PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124479800Oncogenic microRNAs in the genesis of leukemia and lymphoma.Curr Pharm Des2014https://conductscience.org/library/papers/24479800PubMed
226555894miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.Nat Commun2015https://conductscience.org/library/papers/26555894PubMed
320008931Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.Genes Dev2009https://conductscience.org/library/papers/20008931PubMed
421045193The prognostic and functional role of microRNAs in acute myeloid leukemia.Blood2011https://conductscience.org/library/papers/21045193PubMed
524169826The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop.Blood2013https://conductscience.org/library/papers/24169826PubMed
620133587Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20133587PubMed
724382515MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.J Clin Neurosci2014https://conductscience.org/library/papers/24382515PubMed
827391347SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models.Oncotarget2016https://conductscience.org/library/papers/27391347PubMed
923318438WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells.Oncogene2014https://conductscience.org/library/papers/23318438PubMed
1022238599Rapid generation of microRNA sponges for microRNA inhibition.PLoS One2012https://conductscience.org/library/papers/22238599PubMed
1117694064MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.Nat Methods2007https://conductscience.org/library/papers/17694064PubMed
1227280396Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.Cancer Res2016https://conductscience.org/library/papers/27280396PubMed
1326589915FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.Haematologica2016https://conductscience.org/library/papers/26589915PubMed
1420851997The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence.Cancer Res2010https://conductscience.org/library/papers/20851997PubMed
1520388800Oncogenic role of miR-483-3p at the IGF2/483 locus.Cancer Res2010https://conductscience.org/library/papers/20388800PubMed
16202269628p11 myeloproliferative syndrome: a review.Hum Pathol2010https://conductscience.org/library/papers/20226962PubMed
1727785808A model of BCR-FGFR1 driven human AML in immunocompromised mice.Br J Haematol2016https://conductscience.org/library/papers/27785808PubMed
1812969958FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice.Blood2004https://conductscience.org/library/papers/12969958PubMed
1923967867MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.J Transl Med2013https://conductscience.org/library/papers/23967867PubMed
2022701616Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage.PLoS One2012https://conductscience.org/library/papers/22701616PubMed

See all 50 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42933890CBFB-MYH11 directly activates TGFβ and PD-L1 to drive immune evasion in acute myeloid leukemia.J Immunother Cancer2026https://conductscience.org/library/papers/42933890PubMed
42650865MicroRNAs: A Social Network in Diabetic Retinopathy.Biomolecules2026https://conductscience.org/library/papers/42650865PubMed
39807336Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil via targeting KDM4C/MIR17HG/GSK-3β negative feedback loop in colorectal cancer.Acta Pharm Sin B2024https://conductscience.org/library/papers/39807336PubMed
36924298FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis.CNS Neurosci Ther2023https://conductscience.org/library/papers/36924298PubMed
36408177The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy.Front Oncol2022https://conductscience.org/library/papers/36408177PubMed
34906138IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies.Mol Cancer2021https://conductscience.org/library/papers/34906138PubMed
33305460Deciphering the role of microRNAs in mustard gas-induced toxicity.Ann N Y Acad Sci2021https://conductscience.org/library/papers/33305460PubMed
31628193DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis.J Biol Chem2019https://conductscience.org/library/papers/31628193PubMed
31361891Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications.J Mol Cell Biol2019https://conductscience.org/library/papers/31361891PubMed
31105873BCR: a promiscuous fusion partner in hematopoietic disorders.Oncotarget2019https://conductscience.org/library/papers/31105873PubMed
30854399The MicroRNA Family Both in Normal Development and in Different Diseases: The miR-17-92 Cluster.Biomed Res Int2019https://conductscience.org/library/papers/30854399PubMed
30413411Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice.Cancer Res2019https://conductscience.org/library/papers/30413411PubMed
29735550miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the BCL2L11 and BAX Proapoptotic Genes.Cancer Res2018https://conductscience.org/library/papers/29735550PubMed
29720732FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome.Leukemia2018https://conductscience.org/library/papers/29720732PubMed

Download CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29367757

GET https://conductscience.org/api/papers/v1/29367757/references?page=2